Literature DB >> 1829244

[Infections after massive bone allografts in surgery of bone tumors of the limbs. Incidence, contributing factors, therapeutic problems].

P Hernigou1, G Delepine, D Goutallier.   

Abstract

This study was carried out on a sample of 115 patients receiving massive allografts that were sterilized by irradiation and implanted after tumor resection, and having a remission period of 2-5 years. Among the 11 post-operative infections that occurred, 9 arose early and 2 arose late. The risk of infection was augmented when reconstruction by allograft followed tumor surgery requiring adjuvant chemotherapy and/or radiation treatments. Treatment of these allograft infections was difficult due to the presence of multiple bacteria as well as the general circumstances surrounding the infection (immunosuppressed patients under chemotherapy): 5 of the 11 patients required amputation secondary to infection.

Entities:  

Mesh:

Year:  1991        PMID: 1829244

Source DB:  PubMed          Journal:  Rev Chir Orthop Reparatrice Appar Mot        ISSN: 0035-1040


  4 in total

1.  Effects of Surgical Angiogenesis on Segmental Bone Reconstruction With Cryopreserved Massive-Structural Allografts in a Porcine Tibia Model.

Authors:  Noortje J Visser; Elisa S Rezaie; Patricia F Friedrich; Dimitra Kotsougiani; Alexander Y Shin; Allen T Bishop
Journal:  J Orthop Res       Date:  2019-05-17       Impact factor: 3.494

2.  What Are the Risk Factors and Management Options for Infection After Reconstruction With Massive Bone Allografts?

Authors:  Luis A Aponte-Tinao; Miguel A Ayerza; D Luis Muscolo; Germán L Farfalli
Journal:  Clin Orthop Relat Res       Date:  2016-03       Impact factor: 4.176

3.  Infection in massive bone allografts sterilised by radiation.

Authors:  B Loty; B Tomeno; J Evrard; M Postel
Journal:  Int Orthop       Date:  1994-06       Impact factor: 3.075

4.  [Intraoperative extracorporeal irradiation and replantation in local treatment of primary malignant bone tumors].

Authors:  D Sabo; L Bernd; M Buchner; M Treiber; M Wannenmacher; V Ewerbeck; D Parsch
Journal:  Orthopade       Date:  2003-11       Impact factor: 1.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.